Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer

Oncogene volume 26, pages 1338–1345 (2007)Cite this article

Abstract

The phosphatidyl inositol 3-kinase (PI3K)/Akt pathway is activated downstream of a variety of extracellular signals and activation of this signaling pathway impacts a number of cellular processes including cell growth, proliferation and survival. The alteration of components of this pathway, through either activation of oncogenes or inactivation of tumor suppressors, disrupts a signaling equilibrium and can thus lead to cellular transformation. The frequent dysregulation of the PI3K/Akt pathway in human cancer has made components of this pathway attractive for therapeutic targeting; however, a more comprehensive understanding of the signaling intricacies is necessary to develop pharmacological agents to target not only specific molecules, but also specific functions. Here, we review a series of experiments examining the contribution of molecules of this signaling network including PI3K, phosphatase and tensin homolog deleted on chromosome 10, integrin-linked kinase and Akt and address the significance to human breast cancer.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  • Ackler S, Ahmad S, Tobias C, Johnson MD, Glazer RI . (2002). Delayed mammary gland involution in MMTV-AKT1 transgenic mice. Oncogene 21: 198–206.

    Article  CAS  PubMed  Google Scholar 

  • Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, Quinn MA . (2003). Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. J Pathol 201: 229–237.

    Article  CAS  PubMed  Google Scholar 

  • Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R et al. (2003). Overexpression of Akt2/protein kinase Bβ leads to up-regulation of β1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 63: 196–206.

    CAS  PubMed  Google Scholar 

  • Attwell S, Roskelley C, Dedhar S . (2000). The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19: 3811–3815.

    Article  CAS  PubMed  Google Scholar 

  • Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, Szabo S et al. (2004). The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther 3: 772–775.

    Article  CAS  PubMed  Google Scholar 

  • Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA et al. (1995). Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64: 280–285.

    Article  CAS  PubMed  Google Scholar 

  • Brakebusch C, Fassler R . (2003). The integrin-actin connection, an eternal love affair. EMBO J 22: 2324–2333.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bravou V, Klironomos G, Papadaki E, Taraviras S, Varakis V . (2006). ILK over-expression in human colon cancer progression correlates with activation of β-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway. J Pathol 208: 91–99.

    Article  CAS  PubMed  Google Scholar 

  • Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999). Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96: 857–868.

    Article  CAS  PubMed  Google Scholar 

  • Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T et al. (2001). Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene. Genes Dev 15: 2203–2208.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw III EB et al. (2001a). Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292: 1728–1731.

    Article  CAS  PubMed  Google Scholar 

  • Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ . (2001b). Akt1/PKBα is required for normal growth but dispensible for maintenance of glucose homeostasis in mice. J Biol Chem 276: 38349–38352.

    Article  CAS  PubMed  Google Scholar 

  • Chung DH, Lee JI, Kook MC, Kim JR, Kim SH, Choi EY et al. (1998). ILK (beta1-integrin-linked protein kinase): a novel immunohistochemical marker for Ewing's sarcoma and primitive neuroectodermal tumour. Virchows Arch 433: 113–117.

    Article  CAS  PubMed  Google Scholar 

  • Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA . (1995). Inhibition of glycogen cynthase kinase-3 by insulin mediated protein kinase B. Nature 378: 785–789.

    Article  CAS  PubMed  Google Scholar 

  • Dahia PL, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T et al. (1997). Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 57: 4710–4713.

    CAS  PubMed  Google Scholar 

  • Dai DL, Makretsov N, Campos EI, Huang C, Zhou Y, Huntsman D et al. (2003). Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival. Clin Cancer Res 9: 4409–4414.

    CAS  PubMed  Google Scholar 

  • D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B et al. (2000). The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 275: 32649–32657.

    Article  CAS  PubMed  Google Scholar 

  • Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y et al. (1997). Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231–241.

    Article  CAS  PubMed  Google Scholar 

  • del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G . (1997). Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687–689.

    Article  CAS  PubMed  Google Scholar 

  • Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S . (1998). Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95: 11211–11216.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Deprez J, Vertommen D, Alessi DR, Hue L, Rider MH . (1997). Phosphorylation and activation of heart glucose 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascade. J Biol Chem 272: 17269–17275.

    Article  CAS  PubMed  Google Scholar 

  • Diehl JA, Cheng M, Roussel MF, Sherr CJ . (1998). Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499–3511.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS et al. (2005). Role for Akt3/protein kinase Bγ in attainment of normal brain size. Mol Cell Biol 25: 1869–1878.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Edwards LA, Thiessen B, Dragowska WH, Daynard T, Bally MB, Dedhar S . (2005). Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth. Oncogene 24: 3596–3605.

    Article  CAS  PubMed  Google Scholar 

  • Garcia JM, Silva JM, Dominguez G, Gonzalez R, Navarro A, Carretero L et al. (1999). Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype. Breast Cancer Res Treat 57: 237–243.

    Article  CAS  PubMed  Google Scholar 

  • Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW et al. (2001). Integrin-linked kinase expression increases with prostate tumor grade. Clin Cancer Res 7: 1987–1991.

    CAS  PubMed  Google Scholar 

  • Hanahan D, Weinberg RA . (2000). The hallmarks of cancer. Cell 100: 57–70.

    Article  CAS  PubMed  Google Scholar 

  • Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J et al. (1996). Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379: 91–96.

    Article  CAS  PubMed  Google Scholar 

  • Hennessy BT, Smith DL, Ram PT, Lu T, Mills GB . (2005). Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Disc 4: 988–1004.

    Article  CAS  Google Scholar 

  • Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ . (2001). Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol 21: 2203–2212.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hutchinson JN, Jin J, Cardiff RD, Woodgett JR, Muller WJ . (2004). Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res 64: 3171–3178.

    Article  CAS  PubMed  Google Scholar 

  • Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N et al. (2005). Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 171: 1023–1034.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kane LP, Shapiro VS, Stokoe D, Weiss A . (1999). Induction of NF-κB by the Akt/PKB kinase. Curr Biol 9: 601–604.

    Article  CAS  PubMed  Google Scholar 

  • Kang S, Bader AG, Vogt PK . (2005). Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA 102: 802–807.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kawakami Y, Nishimoto H, Kitaura J, Maeda-Yamamoto M, Kato RM, Littman DR et al. (2004). Protein kinase C βII regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. J Biol Chem 279: 47720–47725.

    Article  CAS  PubMed  Google Scholar 

  • Kohn AD, Summers SA, Birnbaum MJ, Roth RA . (1996). Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372–31378.

    Article  CAS  PubMed  Google Scholar 

  • Koul D, Shen R, Bergh S, Lu Y, de Groot JF, Liu TJ et al. (2005). Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Mol Cancer Ther 4: 1681–1688.

    Article  CAS  PubMed  Google Scholar 

  • Larue L, Bellacosa A . (2005). Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene Rev 24: 7443–7454.

    Article  CAS  Google Scholar 

  • Li G, Robinson GW, Lesche R, Martinez-Diaz H, Jiang Z, Rozengurt N et al. (2002). Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 129: 4159–4170.

    Article  CAS  PubMed  Google Scholar 

  • Li Y, Corradetti MN, Inoki K, Guan KL . (2004). TSC2: Filling the GAP in the mTOR signaling pathway. Trends Biochem Sci 29: 32–38.

    Article  PubMed  CAS  Google Scholar 

  • Li Y, Podsypanina K, Liu X, Crane A, Tan LK, Parsons R et al. (2001). Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice. BMC Mol Biol 2: 2–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z et al. (1997). Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16: 64–67.

    Article  CAS  PubMed  Google Scholar 

  • Lynch DK, Ellis CA, Edwards PA, Hiles ID . (1999). Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene 18: 8024–8032.

    Article  CAS  PubMed  Google Scholar 

  • Mackinnon AC, Qadota H, Norman KR, Moerman DG, Williams BD . (2002). C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr Biol 12: 787–797.

    Article  CAS  PubMed  Google Scholar 

  • Marotta A, Tan C, Gray V, Malik S, Gallinger S, Sanghera J et al. (2001). Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis. Oncogene 20: 6250–6257.

    Article  CAS  PubMed  Google Scholar 

  • Minobe K, Bando K, Fukino K, Soma S, Kasumi F, Sakamoto G et al. (1999). Somatic mutation of the PTEN/MMAC1 gene in breast cancers with microsatellite instability. Cancer Lett 144: 9–16.

    Article  CAS  PubMed  Google Scholar 

  • Nakatani K, Thompson DA, Barthel A, Sakaue H, Liu W, Weigel RJ et al. (1999). Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem 274: 21528–21532.

    Article  CAS  PubMed  Google Scholar 

  • Nelen MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H et al. (1997). Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 6: 1383–1387.

    Article  CAS  PubMed  Google Scholar 

  • Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Donner DB . (1999). NF-κB activation by tumor necrosis factor required the Akt serine-threonine kinase. Nature 401: 82–85.

    Article  CAS  PubMed  Google Scholar 

  • Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J et al. (2000). Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA 97: 3207–3212.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D et al. (2001). Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase. Critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 276: 27462–27469.

    Article  CAS  PubMed  Google Scholar 

  • Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI, Boyd J . (1997). Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 57: 3657–3659.

    CAS  PubMed  Google Scholar 

  • Romashkova JA, Makarov SS . (1999). NF-κB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401: 86–90.

    Article  CAS  PubMed  Google Scholar 

  • Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X et al. (2005). PIK3CA mutations correlate with hormone receptors, node metastasis, and ErbB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res 65: 2554–2559.

    Article  CAS  PubMed  Google Scholar 

  • Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554.

    Article  CAS  PubMed  Google Scholar 

  • Sarbassov DD, Guertin DA, Ali AM, Sabatini DM . (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098–1101.

    Article  CAS  PubMed  Google Scholar 

  • Schwertfeger KL, McManaman JL, Palmer CA, Neville MC, Anderson SM . (2003). Expression of constitutively activated Akt in the mammary gland leads to excess lipid synthesis during pregnancy and lactation. J Lipid Res 44: 1100–1112.

    Article  CAS  PubMed  Google Scholar 

  • Schwertfeger KL, Richert MM, Anderson SM . (2001). Mammary gland involution is delayed by activated akt in transgenic mice. Mol Endocrinol 15: 867–881.

    Article  CAS  PubMed  Google Scholar 

  • Sizemore N, Leung S, Stark GR . (1999). Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit. Mol Cell Biol 19: 4798–4805.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stal O, Perez-Tenotio G, Akerberg L, Olsson B, Nordenskjold B, Skoog L et al. (2003). Akt kinases in breast cancer and the results of adjuvant therapy. Breast Cancer Res 5: R37–R44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WB, Mak TW . (2000). High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/− mice. Cancer Res 60: 3605–3611.

    CAS  PubMed  Google Scholar 

  • Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH et al. (1997). Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356–362.

    Article  CAS  PubMed  Google Scholar 

  • Sun M, Wang G, Paciga JE, Feldman RI, Yuan ZQ, Ma X et al. (2001). AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol 159: 431–437.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tan C, Cruet-Hennequart S, Troussard A, Fazli L, Costello P, Sutton K et al. (2004). Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell 5: 79–90.

    Article  CAS  PubMed  Google Scholar 

  • Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C et al. (1997). MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57: 5221–5225.

    CAS  PubMed  Google Scholar 

  • Thant AA, Nawa A, Kikkawa F, Ichigotani Y, Zhang Y, Sein TT et al. (2000). Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells. Clin Exp Metastasis 18: 423–428.

    Article  CAS  PubMed  Google Scholar 

  • Toker A, Newton AC . (2000). Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J Biol Chem 275: 8271–8274.

    Article  CAS  PubMed  Google Scholar 

  • Tschopp O, Yang Z-Z, Brodbeck D, Duemmler B, Hemmings-Mieszczak M, Watanabe T et al. (2005). Essential role of protein kinase Bγ (PKBγ/Akt3) in postnatal brain development, but not for glucose homeostasis. Development 132: 2943–2954.

    Article  CAS  PubMed  Google Scholar 

  • Tu Y, Huang Y, Zhang Y, Hua Y, Wu C . (2001). A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading. J Cell Biol 153: 585–598.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio A, Califano D et al. (2002). Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 8: 1136–1144.

    Article  CAS  PubMed  Google Scholar 

  • Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, Wu H . (2006). Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci USA 103: 1480–1485.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • West KA, Castillo SS, Dennis PA . (2002). Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Update 5: 234–248.

    Article  CAS  Google Scholar 

  • White DE, Cardiff RD, Dedhar S, Muller WJ . (2001). Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 20: 7064–7072.

    Article  CAS  PubMed  Google Scholar 

  • Wu C . (2001). ILK interactions. J Cell Sci 114: 2549–2550.

    Article  CAS  PubMed  Google Scholar 

  • Wu C, Keightley SY, Leung-Hagesteijn C, Radeva G, Coppolino M, Goicoechea S et al. (1998). Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem 273: 528–536.

    Article  CAS  PubMed  Google Scholar 

  • Yamaji S, Suzuki A, Sugiyama Y, Koide Y, Yoshida MKH, Mohri H et al. (2001). A novel integrin-linked kinase-binding protein, affixin, is involved in the early stage of cell-substrate interaction. J Cell Biol 153: 1251–1264.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A . (2005). Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 20: 539–550.

    Article  CAS  PubMed  Google Scholar 

  • Younes MN, Kim S, Yigitbasi OG, Mandal M, Jasser SA, Dakak Yazici Y et al. (2005). Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer. Mol Cancer Ther 4: 1146–1156.

    Article  CAS  PubMed  Google Scholar 

  • Zervas CG, Brown NH . (2002). Integrin adhesion: when is a kinase a kinase? Curr Biol 152: R350–R351.

    Article  Google Scholar 

  • Zervas CG, Gregory SL, Brown NH . (2001). Drosophila integrin-linked kinase is required at sites of integrin adhesion to link the cytoskeleton to the plasma membrane. J Cell Biol 12: 1007–1018.

    Article  Google Scholar 

  • Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC . (2001). Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3: E71–E73.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

WJM is supported by CRC Chair in Molecular Oncology. RLD is supported by a pre-doctoral award from the DOD. This work was supported by grants from NCI PPG #102036 and CBCRA awarded to WJM.

Author information

Authors and Affiliations

  1. Molecular Oncology Group and Departments of Biochemistry and Medicine, McGill University, Montreal, Quebec, Canada

    R L Dillon, D E White & W J Muller

Authors
  1. R L Dillon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D E White
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W J Muller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W J Muller.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Dillon, R., White, D. & Muller, W. The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer. Oncogene 26, 1338–1345 (2007). https://doi.org/10.1038/sj.onc.1210202

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210202

Keywords

  • PI3K
  • Akt
  • PTEN
  • ILK
  • breast cancer

This article is cited by

Search

Advanced search

Quick links